{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:47:26Z","timestamp":1757699246646},"reference-count":94,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["bprch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.beha.2013.04.007","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T11:02:04Z","timestamp":1369306924000},"page":"75-87","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pathobiology of T-cell and NK-cell lymphomas"],"prefix":"10.1016","volume":"26","author":[{"given":"Ewa B.","family":"Bajor-Dattilo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.beha.2013.04.007_bib1","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.beha.2013.04.007_bib2","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"Suppl. 1","key":"10.1016\/j.beha.2013.04.007_bib3","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/modpathol.2012.181","article-title":"Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls","volume":"26","author":"Jaffe","year":"2013","journal-title":"Modern Pathology"},{"issue":"5","key":"10.1016\/j.beha.2013.04.007_bib4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri797","article-title":"Gammadelta T cells: functional plasticity and heterogeneity","volume":"2","author":"Carding","year":"2002","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"10.1016\/j.beha.2013.04.007_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1525-1578(10)60610-1","article-title":"Hepatosplenic and subcutaneous panniculitis-like gamma\/delta T cell lymphomas are derived from different Vdelta subsets of gamma\/delta T lymphocytes","volume":"2","author":"Przybylski","year":"2000","journal-title":"The Journal of Molecular Diagnostics: JMD"},{"issue":"12","key":"10.1016\/j.beha.2013.04.007_bib6","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.beha.2013.04.007_bib7","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"12","key":"10.1016\/j.beha.2013.04.007_bib8","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000478-200312000-00003","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15","volume":"27","author":"Barry","year":"2003","journal-title":"The American Journal of Surgical Pathology"},{"issue":"1","key":"10.1016\/j.beha.2013.04.007_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM197501022920101","article-title":"Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease","volume":"292","author":"Lukes","year":"1975","journal-title":"The New England Journal of Medicine"},{"issue":"7866","key":"10.1016\/j.beha.2013.04.007_bib10","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0140-6736(74)90553-4","article-title":"Angio-immunoblastic lymphadenopathy with dysproteinaemia","volume":"1","author":"Frizzera","year":"1974","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.beha.2013.04.007_bib11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","article-title":"Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10","volume":"99","author":"Attygalle","year":"2002","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2013.04.007_bib12","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T cells (TFH)","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2013.04.007_bib13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","article-title":"Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma","volume":"30","author":"Dorfman","year":"2006","journal-title":"The American Journal of Surgical Pathology"},{"issue":"8","key":"10.1016\/j.beha.2013.04.007_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.3800625","article-title":"Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified","volume":"19","author":"Grogg","year":"2006","journal-title":"Modern Pathology"},{"issue":"7","key":"10.1016\/j.beha.2013.04.007_bib15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e31802d68e9","article-title":"Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression","volume":"31","author":"Attygalle","year":"2007","journal-title":"The American Journal of Surgical Pathology"},{"issue":"7","key":"10.1016\/j.beha.2013.04.007_bib16","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V79.7.1789.1789","article-title":"Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma","volume":"79","author":"Weiss","year":"1992","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2013.04.007_bib17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/00000478-199910000-00008","article-title":"Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection","volume":"23","author":"Quintanilla-Martinez","year":"1999","journal-title":"The American Journal of Surgical Pathology"},{"issue":"6","key":"10.1016\/j.beha.2013.04.007_bib18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e3182785610","article-title":"Peripheral t-cell lymphoma of follicular t-helper cell derivation with Hodgkin\/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist","volume":"37","author":"Nicolae","year":"2013","journal-title":"The American Journal of Surgical Pathology"},{"issue":"1","key":"10.1016\/j.beha.2013.04.007_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood.V82.1.241.bloodjournal821241","article-title":"B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus","volume":"82","author":"Abruzzo","year":"1993","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2013.04.007_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1309\/6UTX-GVC0-12ND-JJEU","article-title":"Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified","volume":"117","author":"Zettl","year":"2002","journal-title":"American Journal of Clinical Pathology"},{"issue":"9","key":"10.1016\/j.beha.2013.04.007_bib21","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/PAS.0b013e3180339f18","article-title":"Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral t-cell lymphomas: a phenomenon with distinctive clinicopathologic features","volume":"31","author":"Balague","year":"2007","journal-title":"The American Journal of Surgical Pathology"},{"issue":"2","key":"10.1016\/j.beha.2013.04.007_bib22","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1200\/JCO.2012.43.3797","article-title":"Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation","volume":"31","author":"Huppmann","year":"2013","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.beha.2013.04.007_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00000478-200401000-00005","article-title":"CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma","volume":"28","author":"Attygalle","year":"2004","journal-title":"The American Journal of Surgical Pathology"},{"issue":"1","key":"10.1016\/j.beha.2013.04.007_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1309\/AJCP62WRKERPXDRT","article-title":"Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma","volume":"131","author":"Yu","year":"2009","journal-title":"American Journal of Clinical Pathology"},{"issue":"5","key":"10.1016\/j.beha.2013.04.007_bib25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma","volume":"148","author":"de Leval","year":"2010","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1016\/j.beha.2013.04.007_bib26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2559.2007.02632.x","article-title":"Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics","volume":"50","author":"Attygalle","year":"2007","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.beha.2013.04.007_bib27","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2353\/jmoldx.2006.060016","article-title":"The frequency of B- and T-cell gene rearrangements and Epstein-Barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations","volume":"8","author":"Tan","year":"2006","journal-title":"The Journal of Molecular Diagnostics: JMD"},{"issue":"2","key":"10.1016\/j.beha.2013.04.007_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project","volume":"31","author":"Federico","year":"2013","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"4","key":"10.1016\/j.beha.2013.04.007_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MOH.0b013e328186ffbf","article-title":"Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications","volume":"14","author":"Dunleavy","year":"2007","journal-title":"Current Opinion in Hematology"},{"issue":"3","key":"10.1016\/j.beha.2013.04.007_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000478-200103000-00015","article-title":"Peripheral T-cell lymphoma with follicular involvement and a CD4+\/bcl-6+ phenotype","volume":"25","author":"de Leval","year":"2001","journal-title":"The American Journal of Surgical Pathology"},{"issue":"4","key":"10.1016\/j.beha.2013.04.007_bib31","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2559.2011.03981.x","article-title":"Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive","volume":"59","author":"Agostinelli","year":"2011","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.beha.2013.04.007_bib32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas","volume":"33","author":"Huang","year":"2009","journal-title":"The American Journal of Surgical Pathology"},{"issue":"10","key":"10.1016\/j.beha.2013.04.007_bib33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00000478-200110000-00008","article-title":"Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells?","volume":"25","author":"de Leval","year":"2001","journal-title":"The American Journal of Surgical Pathology"},{"issue":"3","key":"10.1016\/j.beha.2013.04.007_bib34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2141.2008.07352.x","article-title":"Peripheral T-cell lymphoma with a follicular growth pattern: derivation from follicular helper T cells and relationship to angioimmunoblastic T-cell lymphoma","volume":"143","author":"Bacon","year":"2008","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10.1016\/j.beha.2013.04.007_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00428-005-0123-z","article-title":"Peripheral T-cell lymphoma with involvement of the expanded mantle zone","volume":"449","author":"Ikonomou","year":"2006","journal-title":"Virchows Archiv: An International Journal of Pathology"},{"issue":"11","key":"10.1016\/j.beha.2013.04.007_bib36","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/PAS.0b013e318268d9ff","article-title":"Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics","volume":"36","author":"Moroch","year":"2012","journal-title":"The American Journal of Surgical Pathology"},{"issue":"7","key":"10.1016\/j.beha.2013.04.007_bib37","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2013.04.007_bib38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK"},{"issue":"1","key":"10.1016\/j.beha.2013.04.007_bib39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ajcp\/103.1.82","article-title":"Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance","volume":"103","author":"Fraga","year":"1995","journal-title":"American Journal of Clinical Pathology"},{"issue":"3","key":"10.1016\/j.beha.2013.04.007_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/modpathol.3880289","article-title":"Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology","volume":"14","author":"Jaffe","year":"2001","journal-title":"Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc."},{"issue":"10","key":"10.1016\/j.beha.2013.04.007_bib41","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood-2004-03-1037","article-title":"Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling","volume":"104","author":"Bonzheim","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2013.04.007_bib42","first-page":"2697","article-title":"ALK+ lymphoma: clinico-pathological findings and outcome","volume":"93","author":"Falini","year":"1999","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2013.04.007_bib43","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2013.04.007_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1008352726155","article-title":"Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children \u2013 a report from the French Society of Pediatric Oncology","volume":"11","author":"Brugieres","year":"2000","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology\/ESMO"},{"issue":"35","key":"10.1016\/j.beha.2013.04.007_bib45","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1200\/JCO.2011.36.5411","article-title":"Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study","volume":"29","author":"Lamant","year":"2011","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.beha.2013.04.007_bib46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.critrevonc.2012.06.004","article-title":"Anaplastic large cell lymphoma, ALK-negative","volume":"85","author":"Ferreri","year":"2013","journal-title":"Critical Reviews in Oncology\/hematology"},{"issue":"5","key":"10.1016\/j.beha.2013.04.007_bib47","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2007.06924.x","article-title":"Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas","volume":"140","author":"Salaverria","year":"2008","journal-title":"British Journal of Haematology"},{"issue":"5","key":"10.1016\/j.beha.2013.04.007_bib48","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.humpath.2005.03.004","article-title":"Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas","volume":"36","author":"Thompson","year":"2005","journal-title":"Human Pathology"},{"issue":"5","key":"10.1016\/j.beha.2013.04.007_bib49","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2006-06-028969","article-title":"Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes","volume":"109","author":"Lamant","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2013.04.007_bib50","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2013.04.007_bib51","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2013.04.007_bib52","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2013.04.007_bib53","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/modpathol.2012.38","article-title":"Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders","volume":"25","author":"Sciallis","year":"2012","journal-title":"Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc."},{"issue":"5","key":"10.1016\/j.beha.2013.04.007_bib54","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/PAS.0b013e3182487158","article-title":"Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma","volume":"36","author":"Eberle","year":"2012","journal-title":"The American Journal of Surgical Pathology"},{"issue":"1","key":"10.1016\/j.beha.2013.04.007_bib55","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.2012.065664","article-title":"ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases \u2013 a report from the ALCL99 study","volume":"98","author":"Oschlies","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.beha.2013.04.007_bib56","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/leu.2008.320","article-title":"Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas","volume":"23","author":"Feldman","year":"2009","journal-title":"Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK"},{"issue":"4","key":"10.1016\/j.beha.2013.04.007_bib57","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2011","journal-title":"Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc."},{"issue":"15","key":"10.1016\/j.beha.2013.04.007_bib58","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.007_bib59","series-title":"WHO classification of tumours of the digestive system","author":"Bosman","year":"2010"},{"issue":"1","key":"10.1016\/j.beha.2013.04.007_bib60","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","article-title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project","volume":"118","author":"Delabie","year":"2011","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.beha.2013.04.007_bib61","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMcp1113994","article-title":"Celiac disease","volume":"367","author":"Fasano","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.beha.2013.04.007_bib62","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1309\/NW2BK1DXB0EQG55H","article-title":"Enteropathy-type T-cell lymphoma","volume":"127","author":"Zettl","year":"2007","journal-title":"American Journal of Clinical Pathology"},{"issue":"5","key":"10.1016\/j.beha.2013.04.007_bib63","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/PAS.0b013e318159b478","article-title":"Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype","volume":"32","author":"de Mascarel","year":"2008","journal-title":"The American Journal of Surgical Pathology"},{"issue":"6","key":"10.1016\/j.beha.2013.04.007_bib64","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1172\/JCI41344","article-title":"IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis","volume":"120","author":"Malamut","year":"2010","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.beha.2013.04.007_bib65","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0016-5085(03)01047-3","article-title":"Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease","volume":"125","author":"Mention","year":"2003","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.beha.2013.04.007_bib66","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/PAS.0b013e318222dfcd","article-title":"Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent gammadelta T-cell receptor expression","volume":"35","author":"Chan","year":"2011","journal-title":"The American Journal of Surgical Pathology"},{"issue":"10","key":"10.1016\/j.beha.2013.04.007_bib67","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1440-1827.2008.02281.x","article-title":"CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients","volume":"58","author":"Akiyama","year":"2008","journal-title":"Pathology International"},{"issue":"7","key":"10.1016\/j.beha.2013.04.007_bib68","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.humpath.2007.11.003","article-title":"Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell","volume":"39","author":"Tung","year":"2008","journal-title":"Human Pathology"},{"issue":"11","key":"10.1016\/j.beha.2013.04.007_bib69","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","article-title":"Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.beha.2013.04.007_bib70","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2013.04.007_bib71","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0037-1963(03)00137-9","article-title":"Gammadelta T-cell lymphomas","volume":"40","author":"Gaulard","year":"2003","journal-title":"Seminars in Hematology"},{"issue":"6","key":"10.1016\/j.beha.2013.04.007_bib72","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","article-title":"Hepatosplenic and other gammadelta T-cell lymphomas","volume":"127","author":"Vega","year":"2007","journal-title":"American Journal of Clinical Pathology"},{"issue":"4","key":"10.1016\/j.beha.2013.04.007_bib73","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1309\/YTTC-F55W-K9CP-EPX5","article-title":"Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients","volume":"113","author":"Wu","year":"2000","journal-title":"American Journal of Clinical Pathology"},{"issue":"2","key":"10.1016\/j.beha.2013.04.007_bib74","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","article-title":"Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease","volume":"44","author":"Mackey","year":"2007","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"8","key":"10.1016\/j.beha.2013.04.007_bib75","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/ibd.20169","article-title":"Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?","volume":"13","author":"Rosh","year":"2007","journal-title":"Inflammatory Bowel Diseases"},{"issue":"11","key":"10.1016\/j.beha.2013.04.007_bib76","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","article-title":"Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta","volume":"75","author":"Farcet","year":"1990","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.beha.2013.04.007_bib77","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1182\/blood-2002-09-2908","article-title":"The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity","volume":"101","author":"Krenacs","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2013.04.007_bib78","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.leu.2404168","article-title":"NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis","volume":"20","author":"Morice","year":"2006","journal-title":"Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK"},{"issue":"3","key":"10.1016\/j.beha.2013.04.007_bib79","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"The American Journal of Surgical Pathology"},{"issue":"5","key":"10.1016\/j.beha.2013.04.007_bib80","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2008-07-166363","article-title":"Gene expression profiling of peripheral T-cell lymphoma including gammadelta T-cell lymphoma","volume":"113","author":"Miyazaki","year":"2009","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.beha.2013.04.007_bib81","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1182\/blood-2011-12-396150","article-title":"Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets","volume":"119","author":"Travert","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.007_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.24462","article-title":"Subcutaneous panniculitis-likeT-cell lymphoma in the pediatric age group: a lymphoma of low malignant potential [published online ahead of print February 4 2013]","author":"Huppmann","year":"2013","journal-title":"Pediatric Blood and Cancer"},{"issue":"4","key":"10.1016\/j.beha.2013.04.007_bib83","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0046-8177(98)90122-8","article-title":"Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes","volume":"29","author":"Kumar","year":"1998","journal-title":"Human Pathology"},{"issue":"7","key":"10.1016\/j.beha.2013.04.007_bib84","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/00000478-199807000-00010","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha\/beta and gamma\/delta subtypes","volume":"22","author":"Salhany","year":"1998","journal-title":"The American Journal of Surgical Pathology"},{"issue":"6","key":"10.1016\/j.beha.2013.04.007_bib85","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.0303-6987.2006.00493.x","article-title":"The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat","volume":"33","author":"Massone","year":"2006","journal-title":"Journal of Cutaneous Pathology"},{"issue":"2","key":"10.1016\/j.beha.2013.04.007_bib86","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2013.04.007_bib87","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/DAD.0b013e3181a84f32","article-title":"Subcutaneous panniculitis-like T-cell lymphoma with overlapping clinicopathologic features of lupus erythematosus: coexistence of 2 entities?","volume":"31","author":"Pincus","year":"2009","journal-title":"The American Journal of Dermatopathology"},{"issue":"1","key":"10.1016\/j.beha.2013.04.007_bib88","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000478-199101000-00002","article-title":"T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome","volume":"15","author":"Gonzalez","year":"1991","journal-title":"The American Journal of Surgical Pathology"},{"issue":"8","key":"10.1016\/j.beha.2013.04.007_bib89","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archderm.136.8.1024","article-title":"Gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study","volume":"136","author":"Toro","year":"2000","journal-title":"Archives of Dermatology"},{"issue":"9","key":"10.1016\/j.beha.2013.04.007_bib90","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.beha.2013.04.007_bib91","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2004-10-3999","article-title":"Proteomic analysis of mantle-cell lyrnphoma by protein microarray","volume":"105","author":"Ghobrial","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2013.04.007_bib92","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/PAS.0b013e31822067d1","article-title":"Nonhepatosplenic gammadelta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation","volume":"35","author":"Garcia-Herrera","year":"2011","journal-title":"The American Journal of Surgical Pathology"},{"issue":"7","key":"10.1016\/j.beha.2013.04.007_bib93","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1182\/blood-2012-05-430918","article-title":"Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience","volume":"120","author":"Rothe","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2013.04.007_bib94","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1517\/13543784.2012.690031","article-title":"Inhibitors of the anaplastic lymphoma kinase","volume":"21","author":"Mologni","year":"2012","journal-title":"Expert Opinion on Drug Delivery"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169261300008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169261300008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T01:56:15Z","timestamp":1595814975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169261300008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S152169261300008X"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2013.04.007","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathobiology of T-cell and NK-cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2013.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}